Abstract
Purpose
This study aimed at determining the effects of bed rest on the skeletal muscle leptin signaling system.
Methods
Deltoid and vastus lateralis muscle biopsies and blood samples were obtained from 12 healthy young men (mean ± SD, BMI 22.8 ± 2.7 kg/m2) before and after 7 days of bed rest. Leptin receptor isoforms (OB-Rs), suppressor of cytokine signaling 3 (SOCS3) and protein tyrosine phosphatase 1B (PTP1B) protein expression and signal transducer and activator of transcription 3 (STAT3) phosphorylation were analyzed by Western blot.
Results
After bed rest basal insulin concentration was increased by 53 % (P < 0.05), the homeostasis model assessment (HOMA) by 40 % (P < 0.05), and serum leptin concentration by 35 % (P < 0.05) with no changes in body fat mass. Although the soluble isoform of the leptin receptor (s-OBR) remained unchanged, the molar excess of leptin over sOB-R was increased by 1.4-fold after bed rest (P < 0.05). OB-Rs and SOCS3 protein expression, and STAT3 phosphorylation level remained unaffected in deltoid and vastus lateralis by bed rest, as PTP1B in the deltoid. PTP1B was increased by 90 % with bed rest in the vastus lateralis (P < 0.05). There was a linear relationship between the increase in vastus lateralis PTP1B and the increase in both basal insulin concentrations (r = 0.66, P < 0.05) and HOMA (r = 0.68, P < 0.05) with bed rest.
Conclusions
One week of bed rest is associated with increased leptin levels without augmenting STAT3 phosphorylation indicating some degree of leptin resistance in skeletal muscle, which can be explained, at least in part, by an elevation of PTP1B protein content in the vastus lateralis muscle.
Similar content being viewed by others
Abbreviations
- AMPK 5′:
-
Adenosine monophosphate-activated protein kinase
- AUC:
-
Area under curve
- BMI:
-
Body mass index
- DEXA:
-
Dual-energy X-ray absorbtiometry
- ELISA:
-
Enzyme-linked immunosorbent assay
- FLI:
-
Molar excess of leptin over s-OBR
- HOMA:
-
Homeostatic model assessment of insulin resistance
- JAK2:
-
Janus kinase 2
- OB-R128:
-
Leptin receptor isoform of 128 kDa
- OB-R170:
-
Leptin receptor isoform of 170 kDa
- OB-R98:
-
Leptin receptor isoform of 98 kDa
- OB-Rb:
-
Long isoform of the leptin receptor
- OB-Rs:
-
Leptin receptor isoforms
- OGTT:
-
Oral glucose tolerance test
- PTP1B:
-
Protein tyrosine phosphatase 1B
- SIRT1:
-
Sirtuin 1
- s-OBR:
-
Soluble isoform of the leptin receptor
- SOCS3:
-
Suppressor of cytokine signaling 3
- STAT3:
-
Signal transducer and activator of transcription 3
- TBS-T:
-
Tris-buffered saline with 0.1 % Tween 20
- VO2max :
-
Maximal oxygen consumption or maximal oxygen uptake
References
Aas AM, Hanssen KF, Berg JP, Thorsby PM, Birkeland KI (2009) Insulin-stimulated increase in serum leptin levels precedes and correlates with weight gain during insulin therapy in type 2 diabetes. J Clin Endocrinol Metab 94:2900–2906
Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ (1997a) Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100:449–458
Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ (1997b) Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 46:1140–1145
Akira S (2000) Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19:2607–2611
Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS (2008) Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294:E918–E927
Amati F (2012) Revisiting the diacylglycerol-induced insulin resistance hypothesis. Obes Rev 13(Suppl 2):40–50
Ara I, Perez-Gomez J, Vicente-Rodriguez G, Chavarren J, Dorado C, Calbet JA (2006) Serum free testosterone, leptin and soluble leptin receptor changes in a 6-week strength-training programme. Br J Nutr 96:1053–1059
Arounleut P, Bowser M, Upadhyay S, Shi XM, Fulzele S, Johnson MH, Stranahan AM, Hill WD, Isales CM, Hamrick MW (2013) Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS ONE 8:e72330
Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MG Jr (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856–859
Bienso RS, Ringholm S, Kiilerich K, Aachmann-Andersen NJ, Krogh-Madsen R, Guerra B, Plomgaard P, van Hall G, Treebak JT, Saltin B, Lundby C, Calbet JA, Pilegaard H, Wojtaszewski JF (2012) GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistance. Diabetes 61:1090–1099
Biolo G, Agostini F, Simunic B, Sturma M, Torelli L, Preiser JC, Deby-Dupont G, Magni P, Strollo F, di Prampero P, Guarnieri G, Mekjavic IB, Pisot R, Narici MV (2008) Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 88:950–958
Bjørbæk C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331
Bjørbæk C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS, Myers MG Jr (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275:40649–40657
Blanc S, Normand S, Pachiaudi C, Duvareille M, Gharib C (2000) Leptin responses to physical inactivity induced by simulated weightlessness. Am J Physiol Regul Integr Comp Physiol 279:R891–R898
Bosutti A, Malaponte G, Zanetti M, Castellino P, Heer M, Guarnieri G, Biolo G (2008) Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab 93:3226–3229
Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS (2002) Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51:2105–2112
Chen YW, Gregory CM, Scarborough MT, Shi R, Walter GA, Vandenborne K (2007) Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 31:510–520
Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2:497–503
Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M (1999) Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J Lab Clin Med 134:115–123
Dela F, Helge JW (2013) Insulin resistance and mitochondrial function in skeletal muscle. Int J Biochem Cell Biol 45:11–15
Dube N, Tremblay ML (2005) Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. Biochim Biophys Acta 1754:108–117
Eckardt K, Taube A, Eckel J (2011) Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 12:163–172
Eguchi M, Gillis LC, Liu Y, Lyakhovsky N, Du M, McDermott JC, Sweeney G (2007) Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells. Mol Cell Endocrinol 267:38–45
Elia M, Stratton R, Stubbs J (2003) Techniques for the study of energy balance in man. Proc Nutr Soc 62:529–537
Fuentes T, Ara I, Guadalupe-Grau A, Larsen S, Stallknecht B, Olmedillas H, Santana A, Helge JW, Calbet JA, Guerra B (2010) Leptin receptor 170 kDa (OB-R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance. Exp Physiol 95:160–171
Guerra B, Santana A, Fuentes T, Delgado-Guerra S, Cabrera-Socorro A, Dorado C, Calbet JA (2007) Leptin receptors in human skeletal muscle. J Appl Physiol 102:1786–1792
Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, Santana A, Ponce-Gonzalez JG, Dorado C, Calbet JA (2008) Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS ONE 3:e3466
Hamrick MW, Herberg S, Arounleut P, He HZ, Shiver A, Qi RQ, Zhou L, Isales CM, Mi QS (2010) The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun 400:379–383
Helge JW, Stallknecht B, Drachmann T, Hellgren LI, Jimenez-Jimenez R, Andersen JL, Richelsen B, Bruun JM (2011) Improved glucose tolerance after intensive life style intervention occurs without changes in muscle ceramide or triacylglycerol in morbidly obese subjects. Acta Physiol (Oxf) 201:357–364
Hikita M, Bujo H, Hirayama S, Takahashi K, Morisaki N, Saito Y (2000) Differential regulation of leptin receptor expression by insulin and leptin in neuroblastoma cells. Biochem Biophys Res Commun 271:703–709
Hilton LK, Loucks AB (2000) Low energy availability, not exercise stress, suppresses the diurnal rhythm of leptin in healthy young women. Am J Physiol Endocrinol Metab 278:E43–E49
Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, Yoshii M, Ozawa K (2008) Endoplasmic reticulum stress induces leptin resistance. Mol Pharmacol 74:1610–1619
Jorgensen SB, O’Neill HM, Sylow L, Honeyman J, Hewitt KA, Palanivel R, Fullerton MD, Oberg L, Balendran A, Galic S, van der Poel C, Trounce IA, Lynch GS, Schertzer JD, Steinberg GR (2013) Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 62:56–64
Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS (2006) STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131:1073–1085
Kiilerich K, Ringholm S, Bienso RS, Fisher JP, Iversen N, van Hall G, Wojtaszewski JF, Saltin B, Lundby C, Calbet JA, Pilegaard H (2011) Exercise-induced pyruvate dehydrogenase activation is not affected by 7 days of bed rest. J Appl Physiol 111:751–757
Krawczewski Carhuatanta KA, Demuro G, Tschop MH, Pfluger PT, Benoit SC, Obici S (2011) Voluntary exercise improves high-fat diet-induced leptin resistance independent of adiposity. Endocrinology 152:2655–2664
Krogh-Madsen R, Thyfault JP, Broholm C, Mortensen OH, Olsen RH, Mounier R, Plomgaard P, van Hall G, Booth FW, Pedersen BK (2010) A 2-wk reduction of ambulatory activity attenuates peripheral insulin sensitivity. J Appl Physiol 108:1034–1040
Kusari J, Kenner KA, Suh KI, Hill DE, Henry RR (1994) Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest 93:1156–1162
Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, Patsch JR (2002) Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 10:597–601
Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J (2001) Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283:982–988
Liu ZJ, Endoh A, Li R, Ohzeki T (2004) Effects of leptin and dexamethasone on long and short leptin receptor mRNA. Pediatr Int 46:561–564
Malmstrom R, Taskinen MR, Karonen SL, Yki-Jarvinen H (1996) Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39:993–996
Murphy JC, McDaniel JL, Mora K, Villareal DT, Fontana L, Weiss EP (2012) Preferential reductions in intermuscular and visceral adipose tissue with exercise-induced weight loss compared with calorie restriction. J Appl Physiol (1985) 112:79–85
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529
Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556
Olmedillas H, Sanchis-Moysi J, Fuentes T, Guadalupe-Grau A, Ponce-Gonzalez JG, Morales-Alamo D, Santana A, Dorado C, Calbet JA, Guerra B (2010) Muscle hypertrophy and increased expression of leptin receptors in the musculus triceps brachii of the dominant arm in professional tennis players. Eur J Appl Physiol 108:749–758
Olmedillas H, Guerra B, Guadalupe-Grau A, Santana A, Fuentes T, Dorado C, Serrano-Sanchez JA, Calbet JA (2011) Training, leptin receptors and SOCS3 in human muscle. Int J Sports Med 32:319–326
Olsen DB, Sacchetti M, Dela F, Ploug T, Saltin B (2005) Glucose clearance is higher in arm than leg muscle in type 2 diabetes. J Physiol 565:555–562
Pedersen BK (2007) Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports 17:196–204
Remesar X, Rafecas I, Fernandez-Lopez JA, Alemany M (1997) Is leptin an insulin counter-regulatory hormone? FEBS Lett 402:9–11
Ringholm S, Bienso RS, Kiilerich K, Guadalupe-Grau A, Aachmann-Andersen NJ, Saltin B, Plomgaard P, Lundby C, Wojtaszewski JF, Calbet JA, Pilegaard H (2011) Bed rest reduces metabolic protein content and abolishes exercise-induced mRNA responses in human skeletal muscle. Am J Physiol Endocrinol Metab 301:E649–E658
Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V (1998) Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544–549
Sainz N, Rodriguez A, Catalan V, Becerril S, Ramirez B, Gomez-Ambrosi J, Fruhbeck G (2009) Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 4:e6808
Schaab M, Kausch H, Klammt J, Nowicki M, Anderegg U, Gebhardt R, Rose-John S, Scheller J, Thiery J, Kratzsch J (2012) Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action. PLoS ONE 7:e34787
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
Speakman JR, Westerterp KR (2010) Associations between energy demands, physical activity, and body composition in adult humans between 18 and 96 y of age. Am J Clin Nutr 92:826–834
Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ (2002) Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283:E187–E192
Steinberg GR, Smith AC, Wormald S, Malenfant P, Collier C, Dyck DJ (2004) Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab 286:E57–E63
Steinberg GR, McAinch AJ, Chen MB, O’Brien PE, Dixon JB, Cameron-Smith D, Kemp BE (2006) The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 91:3592–3597
Stepkowski SM, Chen W, Ross JA, Nagy ZS, Kirken RA (2008) STAT3: an important regulator of multiple cytokine functions. Transplantation 85:1372–1377
St-Pierre J, Tremblay ML (2012) Modulation of leptin resistance by protein tyrosine phosphatases. Cell Metab 15:292–297
Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307–319
Sun Q, van Dam RM, Meigs JB, Franco OH, Mantzoros CS, Hu FB (2010) Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes 59:611–618
van Dielen FM, van ‘t Veer C, Buurman WA, Greve JW (2002) Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 87:1708–1716
Wang Z, Zhou YT, Kakuma T, Lee Y, Kalra SP, Kalra PS, Pan W, Unger RH (2000) Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun 277:20–26
Wolsk E, Mygind H, Grondahl TS, Pedersen BK, van Hall G (2011) The role of leptin in human lipid and glucose metabolism: the effects of acute recombinant human leptin infusion in young healthy males. Am J Clin Nutr 94:1533–1544
Worm D, Vinten J, Beck-Nielsen H (1999) The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling. Diabetologia 42:1146–1149
Yang G, Ge H, Boucher A, Yu X, Li C (2004) Modulation of direct leptin signaling by soluble leptin receptor. Mol Endocrinol 18:1354–1362
Yang Z, Hulver M, McMillan RP, Cai L, Kershaw EE, Yu L, Xue B, Shi H (2012) Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS ONE 7:e47493
Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB (2004) Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279:24844–24851
Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB (2008) Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283:14230–14241
Zastrow O, Seidel B, Kiess W, Thiery J, Keller E, Bottner A, Kratzsch J (2003) The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disord 27:1472–1478
Zhang J, Scarpace PJ (2009) The soluble leptin receptor neutralizes leptin-mediated STAT3 signalling and anorexic responses in vivo. Br J Pharmacol 158:475–482
Zhang F, Chen Y, Heiman M, Dimarchi R (2005) Leptin: structure, function and biology. Vitam Horm 71:345–372
Acknowledgments
The authors would like to thank the subjects for the extraordinary effort and the whole COPENHAGEN BED REST 2008 TEAM for excellent collaboration. Special thanks are given to José Navarro de Tuero for his excellent technical assistance. This study was supported by grants from the Lundbeck Foundation, Denmark, and The Danish Medical Research Council, Denmark, and the Ministerio de Ciencia e Innovación (BFU2006-13784 and FEDER) and FUNCIS (PI/10/07). Borja Guerra was a fellow of the “Recursos Humanos y Difusión de la Investigación” Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain). The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (#02-512-55). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation.
Conflict of interest
The authors report no conflict of interest. The authors alone are responsible for the content and writing the paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Jean-René Lacour.
The human experiments were conducted at Copenhagen Muscle Research Centre, Rigshospitalet, Copenhagen, Denmark.
Rights and permissions
About this article
Cite this article
Guerra, B., Ponce-González, J.G., Morales-Alamo, D. et al. Leptin signaling in skeletal muscle after bed rest in healthy humans. Eur J Appl Physiol 114, 345–357 (2014). https://doi.org/10.1007/s00421-013-2779-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-013-2779-4